Revesta (Sterling Knight Pharmaceuticals,LLC)


Welcome to the PulseAid listing for the Revesta drug offered from Sterling Knight Pharmaceuticals,LLC. This Vitamin D [Chemical/Ingredient],Vitamin D [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sterling Knight Pharmaceuticals,LLC
NON-PROPRIETARY NAME: Revesta
SUBSTANCE NAME: CHOLECALCIFEROL; FOLIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin D [Chemical/Ingredient],Vitamin D [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2016-10-13
END MARKETING DATE: 0000-00-00


Revesta HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRevesta from Sterling Knight Pharmaceuticals,LLC
LABELER NAME: Sterling Knight Pharmaceuticals,LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 5750; 1([iU]/1; mg/1)
START MARKETING DATE: 2016-10-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69336-330_0206c671-3014-44b9-b3e8-4357f393452b
PRODUCT NDC: 69336-330
APPLICATION NUMBER:

Other CHOLECALCIFEROL; FOLIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sterling Knight Pharmaceuticals,LLCDurachol